🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Dow Falls 150 Points; AutoZone Earnings Top Views

Published 19/09/2023, 19:32
© Reuters.  Dow Falls 150 Points; AutoZone Earnings Top Views
UK100
-
US500
-
FCHI
-
DE40
-
ES35
-
IT40
-
JP225
-
HK50
-
DELL
-
AZO
-
GC
-
HG
-
SI
-
SSEC
-
STOXX
-
AVGR
-
RXT
-

Benzinga - by Lisa Levin, Benzinga Editor.

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 150 points on Tuesday.

The Dow traded down 0.48% to 34,457.36 while the NASDAQ fell 0.28% to 13,672.29. The S&P 500 also fell, dropping, 0.34% to 4,438.52.

Check This Out: Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday

Leading and Lagging Sectors

Communication services shares fell by just 0.02% on Tuesday.

In trading on Tuesday, energy shares dipped by 1.1%.

Top Headline

AutoZone Inc (NYSE: AZO) reported better-than-expected earnings for its fourth quarter.

The company posted fourth-quarter FY23 sales growth of 6.4% year-on-year to $5.69 billion, beating the analyst consensus of $5.61 billion. EPS of $46.46 beat the consensus of $45.12.

Equities Trading UP

Rackspace Technology, Inc. (NASDAQ: RXT) shares shot up 36% to $2.0102 after Raymond James upgraded the stock from Market Perform to Outperform and announced a $3.5 price target.

Shares of Avinger, Inc. (NASDAQ: AVGR) got a boost, shooting 41% to $8.53, adding to outsized gains from Monday. On Monday, Avinger shares soared 46.8% after the company announced the commercial launch of its Tigereye ST image-guided CTO crossing device.

Elutia Inc. (NASDAQ: ELUT) shares were also up, gaining 29% to $1.6050 after the company announced the sale of its Orthobiologics business unit to Berkeley Biologics LLC. Elutia announced $26 million private placement of 7,355,869 shares of common stock at $1.4275 per share.

Equities Trading DOWN

60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) shares dropped 19% to $0.8950. 60 Degrees Pharmaceuticals’ subsidiary, 60P Australia Pty Ltd, has withdrawn its investigational new drug (IND) application for ACLR8-LR, a Phase 2B study of the use of tafenoquine in treating COVID-19.

Shares of Histogen Inc. (NASDAQ: HSTO) were down 33% to $0.4401 as the company reported board approval of complete liquidation and dissolution.

Revance Therapeutics, Inc. (NASDAQ: RVNC) was down, falling 21% to $13.20. Revance Therapeutics commenced a plan to exit the OPUL payments business, citing that significant costs and resources required to support OPUL no longer align with the company’s capital allocation priorities.

Also Check This Out: Ocean Power Technologies And 3 Other Stocks Under $1 Insiders Are Buying

Commodities

In commodity news, oil traded up 0.1% to $91.52 while gold traded down 0.1% at $1,951.80.

Silver traded down 0.2% to $23.46 on Tuesday while copper fell 0.7% to $3.7520.

Euro zone

European shares closed mixed today. The eurozone’s STOXX 600 fell 0.04% London’s FTSE 100 rose 0.09% while Spain’s IBEX 35 Index rose 0.48% The German DAX fell 0.40% French CAC 40 rose 0.08%, while Italy’s FTSE MIB Index gained 0.60%.

Annual inflation rate in the Eurozone was revised lower to 5.2% in August versus an initial reading of 5.3%, recording the lowest reading since Jan. 2022. The Eurozone posted a current account surplus of €26.9 billion in July versus a €15.8 billion deficit in the year-ago month.

Italy's current account surplus widened to EUR 5.156 billion in July from EUR 0.795 billion in the year-ago month.

Asia Pacific Markets

Asian markets closed mixed on Tuesday, with Japan’s Nikkei 225 falling 0.87%, Hong Kong’s Hang Seng Index rising 0.37% and China’s Shanghai Composite Index falling 0.03%.

Hong Kong's unemployment rate came in unchanged at 2.8% during the three months ending Aug. 2023.

Economics

The FOMC starts its two-day policy meeting today.

Housing starts in the U.S. fell 11.3% month-over-month to an annualized rate of 1.283 million in August, recording the lowest level since June 2020.

Building permits rose 6.9% to an annual rate of 1.543 million in August, notching the highest level in 10 months.

Now Read This: Top 5 Energy Stocks That You May Want To Dump In September

COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 108,479,200 cases with around 1,175,350 deaths. India confirmed a total of at least 44,998,210 cases and 531,930 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 695,437,400 cases of COVID-19 worldwide with more than 6,916,330 deaths.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.